Pietro De Placido, Melissa E. Hughes, Caroline Weipert, Sarah L. Sammons, Stefania Morganti, Heather Anne Parsons, Daniel Abravanel, Antonio Giordano, Kalie Smith, Ashka Patel, Gregory John Kirkner, Catherine Stever, Georgia L. Suggs, Kerry Sendrick, Craig Snow, Eric P. Winer, Sara M. Tolaney, Nancy U. Lin, Rinath Jeselsohn. "Use of baseline plasma circulating tumor DNA (ctDNA) to predict duration of endocrine therapy (ET) and CDK4/6 inhibitor (CDK4/6i) therapy (tx) and to analyze intrinsic vs acquired endocrine resistance.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.1075